HomeYMAB • NASDAQ
add
Y-mAbs Therapeutics Inc
Previous close
$11.85
Day range
$11.50 - $12.02
Year range
$4.60 - $20.90
Market cap
509.04M USD
Avg Volume
384.43K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 19.93M | -1.58% |
Operating expense | 24.69M | 16.54% |
Net income | -6.63M | -3.74% |
Net profit margin | -33.26 | -5.42% |
Earnings per share | -0.15 | 0.00% |
EBITDA | -6.75M | -137.89% |
Effective tax rate | -2.47% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 75.75M | -18.22% |
Total assets | 123.32M | -10.28% |
Total liabilities | 24.13M | -18.54% |
Total equity | 99.19M | — |
Shares outstanding | 43.88M | — |
Price to book | 5.24 | — |
Return on assets | -13.75% | — |
Return on capital | -17.03% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -6.63M | -3.74% |
Cash from operations | -3.48M | 73.51% |
Cash from investing | — | — |
Cash from financing | 588.00K | — |
Net change in cash | -2.89M | 78.01% |
Free cash flow | -2.87M | 47.36% |
About
Founded
2015
Website
Employees
100